Yuh-Shyan Tsai

6PUBLICATIONS
11CO-AUTHORS
Molecular targetsCancer therapy (excl. chemotherapy and radiation therapy)Major global burdens of diseasePacific Peoples life coursePredictive and prognostic markers
Featured researcher

Get your video featured.

JoVEPublish with JoVE
Journal

Publications (6)

|Oct 28, 2023
Oct4 and Hypoxia Dual-Regulated Oncolytic Adenovirus Armed with shRNA-Targeting Dendritic Cell Immunoreceptor Exerts Potent Antitumor Activity against Bladder Cancer.

Che-Yuan Hu, Chi-Feng Hung, Pi-Che Chen

|Mar 10, 2022
Outcome of Non-Muscle Invasive Upper Tract Urothelial Carcinoma Receiving Endoscopic Ablation: An Inverse Probability of Treatment Weighting Analysis.

Chih-Yu Shen, Yeong-Chin Jou, Wei-Chih Kan

|Dec 10, 2021
Determinants and Dynamic Changes of Generic Quality of Life in Human Bladder Cancer Patients.

Yuh-Shyan Tsai, Tzu-Yi Wu, Yeong-Chin Jou

|Jan 20, 2021
Dynamic Changes of Generic Quality of Life after Different Treatments for Localized Prostate Cancer.

Yao-Lin Kao, Chien-Hui Ou, Sheng-Hsiang Lin

|Jan 07, 2021
Study on the pathophysiological mechanism responsible for lower urinary tract symptoms associated with prostate cancer using an animal model.

Lin-Nei Hsu, Yuh-Shyan Tsai, Hsin-Tzu Tsai

|Feb 06, 2019
Prothymosin-α enhances phosphatase and tensin homolog expression and binds with tripartite motif-containing protein 21 to regulate Kelch-like ECH-associated protein 1/nuclear factor erythroid 2-related factor 2 signaling in human bladder cancer.

Yuh-Shyan Tsai, Yeong-Chin Jou, Hsin-Tzu Tsai

Pageof 1

Frequent Collaborators

2 joint publications

Jung-Der Wang

1 joint publications

Lin-Nei Hsu

1 joint publications

Hsin-Tzu Tsai

1 joint publications

Wen-Pin Su